Both hysterectomy and lymphadenectomy may be omitted in the surgical management of women with stage T1 borderline ovarian tumors (BOTs), especially for those with T1a disease regardless of age, a recent study found. This retrospective study included 4,943 women (mean age 48.7 years; 75.3% had stage T1a disease) from 1988 to 2003 and examined the association of surgery patterns and cause-specific survival (CSS). Researchers found:
- Median follow-up was 15.6 years and 159 (3.2%) women died of BOTs.
- Hysterectomy and lymphadenectomy were performed in 1,909 (38.6%) and 1,295 (26.2%) cases, respectively.
- Surgery patterns differed significantly across age, ethnicity, marital status, year at diagnosis, and tumor size.
- Neither procedure was associated with survival in stage T1 BOTs.
Matsuo K, Machida H, Takiuchi T, et al. Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors. [Published online ahead of print January 25, 2017]. Gynecol Oncol. doi:10.1016/j.ygyno.2017.01.019.
This Week's Must Reads
Must Reads in Gynecologic Cancer
Maternal Factors in Cervical Cancer Prevention, Womens Health Issues; ePub 2019 Jan 10; Charlton, et al
Combined Gynecologic Ca & Pelvic Floor Dysfunction Surgery, Female Pelvic Med Reconstr Surg; ePub 2018 Oct 22; McConnell, et al